Literature DB >> 15691884

Insulin increases the adrenergic stimulation of 5' deiodinase activity and mRNA expression in rat brown adipocytes; role of MAPK and PI3K.

Raquel Martinez-deMena1, Maria-Jesus Obregón.   

Abstract

Type II 5' deiodinase (D2) activity produces triiodothyronine (T3) from thyroxine (T4) and is induced by cold and norepinephrine (NE) in brown adipose tissue. T3 is required for and amplifies the adrenergic stimulation of D2 activity and mRNA in cultured brown adipocytes. D2 is upregulated by insulin and decrease in fasting. We now study the regulation by insulin of the adrenergically induced D2 activity and mRNA in primary cultures of rat brown adipocytes. Insulin alone does not increase D2 activity or mRNA. Insulin-depleted cells show a reduction in the adrenergically induced D2 activity, which is proportional to the length of insulin depletion and is restored after insulin addition. IGFs mimic this effect at higher doses. ERK 1/2 MAPK activity (p44/p42), stimulated by insulin, serum and NE, is an absolute requirement for the adrenergic stimulation of D2 activity and mRNA. PI3K is stimulated by insulin and serum, and NE increases the effect of insulin. The action of insulin on D2 is not due to changes in D2 half-life or in the proteasome-mediated degradation of D2, but it seems to modulate the transcriptional induction mediated by NE. D2 mRNA expression, induced by NE plus T3, is reduced when insulin is withdrawn at early differentiation stages. Insulin or IGF-I promotes increases in D2 mRNA. Insulin is required for the induction of D2 mRNA by T3. In conclusion, MAPK signaling is required for the adrenergic stimulation of D2 activity and mRNA, and insulin stimulates D2 activity via MAPK and PI3K and enhances the adrenergic pathways.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15691884     DOI: 10.1677/jme.1.01568

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  15 in total

Review 1.  Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling.

Authors:  Balázs Gereben; Ann Marie Zavacki; Scott Ribich; Brian W Kim; Stephen A Huang; Warner S Simonides; Anikó Zeöld; Antonio C Bianco
Journal:  Endocr Rev       Date:  2008-09-24       Impact factor: 19.871

Review 2.  Paradigms of Dynamic Control of Thyroid Hormone Signaling.

Authors:  Antonio C Bianco; Alexandra Dumitrescu; Balázs Gereben; Miriam O Ribeiro; Tatiana L Fonseca; Gustavo W Fernandes; Barbara M L C Bocco
Journal:  Endocr Rev       Date:  2019-08-01       Impact factor: 19.871

Review 3.  Nutritional and non-nutritional agents that stimulate white adipose tissue browning.

Authors:  F Concha; G Prado; J Quezada; A Ramirez; N Bravo; C Flores; J J Herrera; N Lopez; D Uribe; L Duarte-Silva; P Lopez-Legarrea; Diego F Garcia-Diaz
Journal:  Rev Endocr Metab Disord       Date:  2019-06       Impact factor: 6.514

4.  IL-6 promotes nonthyroidal illness syndrome by blocking thyroxine activation while promoting thyroid hormone inactivation in human cells.

Authors:  Simone Magagnin Wajner; Iuri Martin Goemann; Ana Laura Bueno; P Reed Larsen; Ana Luiza Maia
Journal:  J Clin Invest       Date:  2011-04-11       Impact factor: 14.808

5.  Insulin stimulates interleukin-6 expression and release in LS14 human adipocytes through multiple signaling pathways.

Authors:  Christopher R LaPensee; Eric R Hugo; Nira Ben-Jonathan
Journal:  Endocrinology       Date:  2008-07-10       Impact factor: 4.736

Review 6.  Adipose tissue browning and metabolic health.

Authors:  Alexander Bartelt; Joerg Heeren
Journal:  Nat Rev Endocrinol       Date:  2013-10-22       Impact factor: 43.330

7.  Coupling between Nutrient Availability and Thyroid Hormone Activation.

Authors:  Lattoya J Lartey; João Pedro Werneck-de-Castro; InSug O-Sullivan; Terry G Unterman; Antonio C Bianco
Journal:  J Biol Chem       Date:  2015-10-23       Impact factor: 5.486

8.  Regulation of glucose homeostasis by KSR1 and MARK2.

Authors:  Paula J Klutho; Diane L Costanzo-Garvey; Robert E Lewis
Journal:  PLoS One       Date:  2011-12-19       Impact factor: 3.240

9.  TSH and Thyrotropic Agonists: Key Actors in Thyroid Homeostasis.

Authors:  Johannes W Dietrich; Gabi Landgrafe; Elisavet H Fotiadou
Journal:  J Thyroid Res       Date:  2012-12-30

Review 10.  Deiodinases and the Metabolic Code for Thyroid Hormone Action.

Authors:  Samuel C Russo; Federico Salas-Lucia; Antonio C Bianco
Journal:  Endocrinology       Date:  2021-08-01       Impact factor: 5.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.